Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Statement of Comprehensive Income

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Amgen Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Gains (losses) on foreign currency translation
Gains (losses) on cash flow hedges
Gains (losses) on available-for-sale securities
Other
Other comprehensive income (loss), net of taxes
Comprehensive income

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Amgen Inc. net income increased from 2021 to 2022 and from 2022 to 2023.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Amgen Inc. comprehensive income increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.